9,701
Views
20
CrossRef citations to date
0
Altmetric
Health Technology

Asian innovation in pharmaceutical and medical device industry – beyond tomorrow

ORCID Icon, , , , &
Pages 42-50 | Received 13 Aug 2021, Accepted 30 Nov 2021, Published online: 17 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Kichan Yoon, Han-Kyoul Kim, Mankyu Choi, Munjae Lee & Mihajlo Jakovljevic. (2023) Analyzing the Effectiveness of Data-Linked Projects for Health Promotion in Public Health Centers of South Korea. Risk Management and Healthcare Policy 16, pages 1101-1117.
Read now
Sewon Park, Han-Kyoul Kim, Haeng-Jun Lee, Mankyu Choi, Munjae Lee & Mihajlo Jakovljevic. (2023) Strategic management and organizational culture of medical device companies in relation to corporate performance. Journal of Medical Economics 26:1, pages 781-792.
Read now
Mihajlo Jakovljevic, Chia Jie Tan, Nathorn Chaiyakunapruk, Guilherme Silva Julian, Kei Long Cheung, Mickael Hiligsmann, Brian Godman, Sylvia Opanga, Paul A. Scuffham & Michael Gregg. (2022) Global article collection: essential reads from around the world. Journal of Medical Economics 25:1, pages 864-869.
Read now
Binaya Sapkota, Subish Palaian, Sunil Shrestha, Akihiko Ozaki, Mohamed Izham Mohamed Ibrahim & Mihajlo Jakovljevic. (2022) Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1043-1050.
Read now
Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira & Augusto A Guerra Junior. (2022) Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions. Expert Review of Pharmacoeconomics & Outcomes Research 22:6, pages 927-939.
Read now

Articles from other publishers (15)

Abeer Alharbi. (2023) Knowledge, attitude and practice toward the mHealth app Mawid: a cross-sectional study. International Health 15:3, pages 342-350.
Crossref
Bingbing Ren, Qin He, Jianhua Ma & Gexiang Zhang. (2023) A preliminary analysis of global neonatal disorders burden attributable to PM2.5 from 1990 to 2019. Science of The Total Environment 870, pages 161608.
Crossref
Mihajlo Jakovljevic, Tetsuji Yamada & Danko Grujic. (2023) Editorial: Role of health economic data in policy making and reimbursement of new medical technologies, Volume II. Frontiers in Public Health 11.
Crossref
Mihajlo Jakovljevic, Hanyu Chang & Narimasa Kumagai. (2023) Editorial: Global excellence in health economics: Asia and Australasia. Frontiers in Public Health 11.
Crossref
Reda Cherif & Fuad Hasanov. (2023) Testing our way out of pandemics. Health Policy and Technology 12:1, pages 100714.
Crossref
Mihajlo Jakovljevic, Liang Wang & Chiranjivi Adhikari. (2023) Editorial: Asian health sector growth in the next decade—Optimism despite challenges ahead. Frontiers in Public Health 11.
Crossref
Aude Christelle Ka’e, Alex Durand Nka, Bouba Yagai, Irénée Domkam Kammogne, Ezechiel Ngoufack Jagni Semengue, Aubin Joseph Nanfack, Celine Nkenfou, Michel Carlos Tommo Tchouaket, Desire Takou, Samuel Martin Sosso, Nadine Fainguem, Aissatou Abba, Willy Pabo, Nelly Kamgaing, Edith Temgoua, Boris Tchounga, Patrice Tchendjou, Suzie Tetang, Anne Esther Njom Nlend, Francesca Ceccherini-Silberstein, Maria Mercedes Santoro & Joseph Fokam. (2023) The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies. PLOS ONE 18:1, pages e0278670.
Crossref
Chhabi Lal Ranabhat & Mihajlo Jakovljevic. (2023) Sustainable Health Care Provision Worldwide: Is There a Necessary Trade-Off between Cost and Quality?. Sustainability 15:2, pages 1372.
Crossref
Arcadio A. Cerda, Leidy Y. García, Jennifer Rivera-Arroyo, Andrés Riquelme, Joao Paulo Teixeira & Mihajlo Jakovljevic. (2022) Comparison of the healthcare system of Chile and Brazil: strengths, inefficiencies, and expenditures. Cost Effectiveness and Resource Allocation 20:1.
Crossref
Vanida Prasert, Montarat Thavorncharoensap & Pasitpon Vatcharavongvan. (2022) Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method. Research in Social and Administrative Pharmacy 18:11, pages 3911-3919.
Crossref
Yang Wang, Kai Xu, Yuchen Wang, Weijie Ye, Xinyi Hao, Shouli Wang, Kun Li & Jun Du. (2022) Investigation and analysis of four countries’ recalls of osteosynthesis implants and joint replacement implants from 2011 to 2021. Journal of Orthopaedic Surgery and Research 17:1.
Crossref
Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd & Isabelle Huys. (2022) How to balance valuable innovation with affordable access to medicines in Belgium?. Frontiers in Pharmacology 13.
Crossref
Mihajlo Jakovljevic, Asankha Pallegedara, Thanabalasingam Vinayagathasan & Ajantha Sisira Kumara. (2022) Editorial: Inequality in healthcare utilization and household spending in developing countries. Frontiers in Public Health 10.
Crossref
Xintao Li, Zaisheng Zhang, Li Liu, Tongshun Cheng & Gang Liu. (2022) Analysis of the Quantitative Evaluation of the Public Medical and Health System Costs During Pandemic Governance: Investigation Based on COVID-19. Frontiers in Public Health 10.
Crossref
Vagner Sargiani, Alexandra A. De Souza, Danilo Candido De Almeida, Thiago S. Barcelos, Roberto Munoz & Leandro Augusto Da Silva. (2022) Supporting Clinical COVID-19 Diagnosis with Routine Blood Tests Using Tree-Based Entropy Structured Self-Organizing Maps. Applied Sciences 12:10, pages 5137.
Crossref